000 | 01913 a2200553 4500 | ||
---|---|---|---|
005 | 20250516071230.0 | ||
264 | 0 | _c20120619 | |
008 | 201206s 0 0 eng d | ||
022 | _a1527-3350 | ||
024 | 7 |
_a10.1002/hep.25534 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aYang, Ying-Ying | |
245 | 0 | 0 |
_aHepatic endothelin-1 and endocannabinoids-dependent effects of hyperleptinemia in nonalcoholic steatohepatitis-cirrhotic rats. _h[electronic resource] |
260 |
_bHepatology (Baltimore, Md.) _cMay 2012 |
||
300 |
_a1540-50 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBiopsy, Needle |
650 | 0 | 4 | _aBody Weight |
650 | 0 | 4 |
_aCannabinoid Receptor Modulators _xmetabolism |
650 | 0 | 4 | _aDiet, High-Fat |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 | _aEndocannabinoids |
650 | 0 | 4 |
_aEndothelin-1 _xmetabolism |
650 | 0 | 4 |
_aFatty Liver _xcomplications |
650 | 0 | 4 |
_aHepatic Stellate Cells _xmetabolism |
650 | 0 | 4 |
_aHypertension, Portal _xcomplications |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 |
_aInsulin Resistance _xphysiology |
650 | 0 | 4 |
_aKupffer Cells _xmetabolism |
650 | 0 | 4 |
_aLeptin _xmetabolism |
650 | 0 | 4 |
_aLiver _xmetabolism |
650 | 0 | 4 | _aMicrocirculation |
650 | 0 | 4 | _aNon-alcoholic Fatty Liver Disease |
650 | 0 | 4 |
_aRNA, Messenger _xanalysis |
650 | 0 | 4 | _aRandom Allocation |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Zucker |
650 | 0 | 4 | _aStatistics, Nonparametric |
700 | 1 | _aTsai, Tung-Hu | |
700 | 1 | _aHuang, Yi-Tsau | |
700 | 1 | _aLee, Tzung-Yan | |
700 | 1 | _aChan, Che-Chang | |
700 | 1 | _aLee, Kuei-Chuan | |
700 | 1 | _aLin, Han-Chieh | |
773 | 0 |
_tHepatology (Baltimore, Md.) _gvol. 55 _gno. 5 _gp. 1540-50 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/hep.25534 _zAvailable from publisher's website |
999 |
_c21405214 _d21405214 |